Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
14.52
-0.81 (-5.28%)
At close: Mar 28, 2025, 4:00 PM
14.59
+0.07 (0.45%)
After-hours: Mar 28, 2025, 6:55 PM EDT

Neurogene Statistics

Total Valuation

Neurogene has a market cap or net worth of $216.78 million. The enterprise value is -$83.20 million.

Market Cap 216.78M
Enterprise Value -83.20M

Important Dates

The last earnings date was Monday, March 24, 2025, after market close.

Earnings Date Mar 24, 2025
Ex-Dividend Date n/a

Share Statistics

Neurogene has 14.93 million shares outstanding. The number of shares has increased by 277.22% in one year.

Current Share Class 14.93M
Shares Outstanding 14.93M
Shares Change (YoY) +277.22%
Shares Change (QoQ) +14.84%
Owned by Insiders (%) 10.92%
Owned by Institutions (%) 58.12%
Float 5.55M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 275.76
Forward PS n/a
PB Ratio 0.69
P/TBV Ratio 0.70
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 20.84, with a Debt / Equity ratio of 0.04.

Current Ratio 20.84
Quick Ratio 20.65
Debt / Equity 0.04
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -6,883.75

Financial Efficiency

Return on equity (ROE) is -30.28% and return on invested capital (ROIC) is -19.71%.

Return on Equity (ROE) -30.28%
Return on Assets (ROA) -18.49%
Return on Invested Capital (ROIC) -19.71%
Return on Capital Employed (ROCE) -25.77%
Revenue Per Employee $10,165
Profits Per Employee -$825,758
Employee Count 91
Asset Turnover 0.00
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -70.52% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -70.52%
50-Day Moving Average 16.86
200-Day Moving Average 31.76
Relative Strength Index (RSI) 39.85
Average Volume (20 Days) 219,737

Short Selling Information

The latest short interest is 2.18 million, so 14.60% of the outstanding shares have been sold short.

Short Interest 2.18M
Short Previous Month 1.96M
Short % of Shares Out 14.60%
Short % of Float 39.31%
Short Ratio (days to cover) 12.51

Income Statement

In the last 12 months, Neurogene had revenue of $925,000 and -$75.14 million in losses. Loss per share was -$4.28.

Revenue 925,000
Gross Profit -3.58M
Operating Income -82.61M
Pretax Income -55.44M
Net Income -75.14M
EBITDA -79.36M
EBIT -82.61M
Loss Per Share -$4.28
Full Income Statement

Balance Sheet

The company has $312.41 million in cash and $12.43 million in debt, giving a net cash position of $299.98 million or $20.09 per share.

Cash & Cash Equivalents 312.41M
Total Debt 12.43M
Net Cash 299.98M
Net Cash Per Share $20.09
Equity (Book Value) 310.38M
Book Value Per Share 20.89
Working Capital 300.77M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$70.60 million and capital expenditures -$808,000, giving a free cash flow of -$71.41 million.

Operating Cash Flow -70.60M
Capital Expenditures -808,000
Free Cash Flow -71.41M
FCF Per Share -$4.78
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -8,930.27%
Pretax Margin -8,123.68%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Neurogene does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -277.22%
Shareholder Yield n/a
Earnings Yield -34.66%
FCF Yield -32.94%

Analyst Forecast

The average price target for Neurogene is $59.80, which is 311.85% higher than the current price. The consensus rating is "Strong Buy".

Price Target $59.80
Price Target Difference 311.85%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (5Y) 133.70%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Neurogene has an Altman Z-Score of 10.46 and a Piotroski F-Score of 2.

Altman Z-Score 10.46
Piotroski F-Score 2